SE412389B - Forfarande for framstellning av 1-ftalazon-derivat. - Google Patents

Forfarande for framstellning av 1-ftalazon-derivat.

Info

Publication number
SE412389B
SE412389B SE7413530A SE7413530A SE412389B SE 412389 B SE412389 B SE 412389B SE 7413530 A SE7413530 A SE 7413530A SE 7413530 A SE7413530 A SE 7413530A SE 412389 B SE412389 B SE 412389B
Authority
SE
Sweden
Prior art keywords
phtalazon
derivate
preparing
procedure
phtalazon derivate
Prior art date
Application number
SE7413530A
Other languages
English (en)
Swedish (sv)
Other versions
SE7413530L (xx
Inventor
Inoue Michiro
Ishikawa Masayuki
Tsuchiya Takashi
Shimamoto Takio
Original Assignee
Inoue Michiro
Ishikawa Masayuki
Tsuchiya Takashi
Shimamoto Takio
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP12126073A external-priority patent/JPS5732065B2/ja
Priority claimed from JP12175773A external-priority patent/JPS5724786B2/ja
Application filed by Inoue Michiro, Ishikawa Masayuki, Tsuchiya Takashi, Shimamoto Takio filed Critical Inoue Michiro
Publication of SE7413530L publication Critical patent/SE7413530L/xx
Publication of SE412389B publication Critical patent/SE412389B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/87Benzo [c] furans; Hydrogenated benzo [c] furans
    • C07D307/89Benzo [c] furans; Hydrogenated benzo [c] furans with two oxygen atoms directly attached in positions 1 and 3

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SE7413530A 1973-10-30 1974-10-28 Forfarande for framstellning av 1-ftalazon-derivat. SE412389B (sv)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP12126073A JPS5732065B2 (xx) 1973-10-30 1973-10-30
JP12175773A JPS5724786B2 (xx) 1973-10-31 1973-10-31

Publications (2)

Publication Number Publication Date
SE7413530L SE7413530L (xx) 1975-05-02
SE412389B true SE412389B (sv) 1980-03-03

Family

ID=26458679

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7413530A SE412389B (sv) 1973-10-30 1974-10-28 Forfarande for framstellning av 1-ftalazon-derivat.

Country Status (20)

Country Link
US (1) US3963716A (xx)
AR (1) AR205004A1 (xx)
CA (1) CA1029377A (xx)
CH (2) CH610892A5 (xx)
DD (1) DD119231A5 (xx)
DE (1) DE2451417C3 (xx)
DK (1) DK134345B (xx)
ES (1) ES431454A1 (xx)
FI (1) FI59402C (xx)
FR (1) FR2248841B1 (xx)
GB (1) GB1459606A (xx)
HU (1) HU168797B (xx)
IE (1) IE39831B1 (xx)
IL (1) IL45675A (xx)
IN (1) IN139552B (xx)
LU (1) LU71191A1 (xx)
NL (1) NL7414186A (xx)
PH (1) PH10519A (xx)
SE (1) SE412389B (xx)
YU (1) YU289774A (xx)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4120960A (en) * 1973-10-31 1978-10-17 The Boots Company Limited Therapeutic agents
NL7702763A (nl) * 1976-03-18 1977-09-20 Takio Shimamoto En Masayuki Is Werkwijze voor de bereiding van thromboxaan- -antagonisten en van preparaten die deze stof- fen bevatten.
IE47592B1 (en) * 1977-12-29 1984-05-02 Ici Ltd Enzyme inhibitory phthalazin-4-ylacetic acid derivatives, pharmaceutical compositions thereof,and process for their manufacture
US4293553A (en) * 1978-08-11 1981-10-06 Masayuki Ishikawa 1-Phthalazone derivatives, and use thereof
US4464532A (en) * 1979-07-31 1984-08-07 Nippon Kayaku Kabushiki Kaisha Intermediates of 7-alkoxycarbonyl-6,8-dimethyl-4-hydroxymethyl-1-phthalazone
JPS5668609A (en) * 1979-11-07 1981-06-09 Nippon Kayaku Co Ltd Phthalazinol preparation
JPS58116471A (ja) * 1981-12-29 1983-07-11 Nippon Kayaku Co Ltd 4−ヒドロキシメチル−1−フタラゾンエステル誘導体およびその塩
GB2127805A (en) * 1982-09-13 1984-04-18 Showa Denko Kk Phthalazones
US4861778A (en) * 1986-06-16 1989-08-29 Research Corporation 2,3-dihydrophthalazine-1,4-diones
ES2067508T3 (es) * 1988-08-19 1995-04-01 Warner Lambert Co Dihidroisoquinolinonas sustituidas y compuestos relacionados como potenciadores de los efectos letales de la radiacion y de ciertos agentes quimioterapeuticos; compuestos seleccionados, analogos y proceso.
US5177075A (en) * 1988-08-19 1993-01-05 Warner-Lambert Company Substituted dihydroisoquinolinones and related compounds as potentiators of the lethal effects of radiation and certain chemotherapeutic agents; selected compounds, analogs and process
DE4333761A1 (de) * 1993-10-04 1995-04-06 Luitpold Pharma Gmbh Heterocyclische Carbamate, Verfahren zu ihrer Herstellung und Arzneimittel
US7772188B2 (en) 2003-01-28 2010-08-10 Ironwood Pharmaceuticals, Inc. Methods and compositions for the treatment of gastrointestinal disorders
US7879802B2 (en) 2007-06-04 2011-02-01 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
US20100120694A1 (en) 2008-06-04 2010-05-13 Synergy Pharmaceuticals, Inc. Agonists of Guanylate Cyclase Useful for the Treatment of Gastrointestinal Disorders, Inflammation, Cancer and Other Disorders
US8969514B2 (en) 2007-06-04 2015-03-03 Synergy Pharmaceuticals, Inc. Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases
EP2321341B1 (en) 2008-07-16 2017-02-22 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase useful for the treatment of gastrointestinal, inflammation, cancer and other disorders
KR101701943B1 (ko) 2009-11-13 2017-02-02 도레이 카부시키가이샤 당뇨병의 치료 또는 예방약
US9616097B2 (en) 2010-09-15 2017-04-11 Synergy Pharmaceuticals, Inc. Formulations of guanylate cyclase C agonists and methods of use
MX357121B (es) 2011-03-01 2018-06-27 Synergy Pharmaceuticals Inc Star Proceso de preparacion de agonistas c de guanilato ciclasa.
CA2902348C (en) 2013-02-25 2021-11-30 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase and their uses
EP2970384A1 (en) 2013-03-15 2016-01-20 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase and their uses
CA2905435A1 (en) 2013-03-15 2014-09-25 Synergy Pharmaceuticals Inc. Compositions useful for the treatment of gastrointestinal disorders
BR112015030326A2 (pt) 2013-06-05 2017-08-29 Synergy Pharmaceuticals Inc Agonistas ultrapuros de guanilato ciclase c, método de fabricar e usar os mesmos
WO2015021358A2 (en) 2013-08-09 2015-02-12 Dominique Charmot Compounds and methods for inhibiting phosphate transport
US20200368223A1 (en) 2019-05-21 2020-11-26 Ardelyx, Inc. Methods for inhibiting phosphate transport

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5116430B2 (xx) * 1971-08-05 1976-05-24
US3870792A (en) * 1972-07-24 1975-03-11 Michiro Inoue Certain dihydrophthalizines for treating hemorrhage and thrombosis

Also Published As

Publication number Publication date
DK561874A (xx) 1975-07-07
AU7295474A (en) 1976-03-11
DE2451417C3 (de) 1981-01-29
LU71191A1 (xx) 1975-04-17
IL45675A (en) 1978-10-31
IN139552B (xx) 1976-07-03
CH610892A5 (xx) 1979-05-15
IE39831B1 (en) 1979-01-03
DE2451417B2 (de) 1980-05-14
IL45675A0 (en) 1974-11-29
PH10519A (en) 1977-05-26
HU168797B (xx) 1976-07-28
ES431454A1 (es) 1976-10-16
CH611282A5 (xx) 1979-05-31
IE39831L (en) 1975-04-30
DK134345B (da) 1976-10-25
CA1029377A (en) 1978-04-11
GB1459606A (en) 1976-12-22
SE7413530L (xx) 1975-05-02
FI59402C (fi) 1981-08-10
DD119231A5 (xx) 1976-04-12
AR205004A1 (es) 1976-03-31
DK134345C (xx) 1977-03-21
YU289774A (en) 1983-01-21
FI59402B (fi) 1981-04-30
FR2248841A1 (xx) 1975-05-23
US3963716A (en) 1976-06-15
NL7414186A (nl) 1975-05-02
DE2451417A1 (de) 1975-05-07
FI315774A (xx) 1975-05-01
FR2248841B1 (xx) 1978-07-28

Similar Documents

Publication Publication Date Title
SE412389B (sv) Forfarande for framstellning av 1-ftalazon-derivat.
SE419981B (sv) Forfarande for framstellning av 1alfa-hydroxi-vitamin d-derivat
SE453667B (sv) Forfarande for framstellning av polyeterimider
NO138585C (no) Fremgangsmaate for fremstilling av for for kjaeledyr
SE7508406L (sv) Forfarande for framstellning av polyfenylenoxid.
SE419750B (sv) Forfarande for framstellning av 6-acyl-2,4-dialkyl-2-hydroxicyklohexan-1,35-trion
SE435713B (sv) Forfarande for framstellning av 1,3-bensoxazoler
SE420720B (sv) Forfarande for framstellning av 2,6-disubstuerade fenylaminoguanidinforeningar
SE7508074L (sv) Forfarande for framstellning av stilbenderivat.
SE420098B (sv) Forfarande for framstellning av linkomycinderivat
NO741223L (no) Fremgangsmåte for fremstilling av 6-deoksytetracykliner.
NO740320L (no) Fremgangsmåte for fremstilling 6-deoksyoksytetracyklin.
SE416053B (sv) Forfarande for framstellning av 7alfa-metylostr-4-en-3alfa, 17beta-diol
IT1028069B (it) Procedimento per la preparazione da poliolefine
SE421129B (sv) Forfarande for framstellning av poly-n-alkyl-iminoalaner
NO138376C (no) Fremgangsmaate for fremstilling av 1-beta-d-ribofuranosyl-1, 2, 4-triazol-3-karboksamid
SE408709B (sv) Forfarande for framstellning av indol-, resp azaindol merkatoforeningar
FI55498C (fi) Foerfarande foer framstaellning av hypoglycemiska pyridinkarboxamid-sulfonylureafoereningar
SE401835B (sv) Forfarande for framstellning av 17beta-hydroxi-16,16-dimetylest-4-en-3-on
SE407219B (sv) Forfarande for framstellning av metyl-3-(2--kinoxalinylmetylen)-karbazat-nŸ1,nŸ4-dioxid
TR18287A (tr) Triasetonamin hazirlamaya mahsus usul
SE415100B (sv) Forfarande for framstellning av kinuklidin-kinolinderivat
SE417966B (sv) Forfarande for framstellning av pyrimidinoaminometyl-ergolinderivat
SE390509B (sv) Forfarande for framstellning av skivor av trematerial
SE413497B (sv) Forfarande for framstellning av alkaliperkarbonater.

Legal Events

Date Code Title Description
NUG Patent has lapsed

Ref document number: 7413530-2

Effective date: 19880627

Format of ref document f/p: F